Kim Sugino

Title(s)Clinical Nurse, Women and Infants Services
SchoolVc-health Sciences-health
Address9500 Gilman Drive #
La Jolla CA 92093
vCardDownload vCard

    Collapse Bibliographic 
    Collapse Publications
    Publications listed below are automatically derived from MEDLINE/PubMed and other sources, which might result in incorrect or missing publications. Researchers can login to make corrections and additions, or contact us for help. to make corrections and additions.
    Newest   |   Oldest   |   Most Cited   |   Most Discussed   |   Timeline   |   Field Summary   |   Plain Text
    Altmetrics Details PMC Citations indicate the number of times the publication was cited by articles in PubMed Central, and the Altmetric score represents citations in news articles and social media. (Note that publications are often cited in additional ways that are not shown here.) Fields are based on how the National Library of Medicine (NLM) classifies the publication's journal and might not represent the specific topic of the publication. Translation tags are based on the publication type and the MeSH terms NLM assigns to the publication. Some publications (especially newer ones and publications not in PubMed) might not yet be assigned Field or Translation tags.) Click a Field or Translation tag to filter the publications.
    1. Cutoff age between pediatric and adult thyroid differentiated cancer: Is 18 years old appropriate? Thyroid. 2021 Sep 22. Sugino K, Nagahama M, Kitagawa W, Ohkuwa K, Matsuzu K, Suzuki A, Tomoda C, Hames KY, Akaishi J, Masaki C, Yoshioka K, Ito K. PMID: 34549602.
      View in: PubMed   Mentions:    Fields:    
    2. Impact of lenvatinib on renal function: long-term analysis of differentiated thyroid cancer patients. BMC Cancer. 2021 Aug 05; 21(1):894. Masaki C, Sugino K, Kobayashi S, Hosoi Y, Ono R, Yamazaki H, Akaishi J, Hames KY, Tomoda C, Suzuki A, Matsuzu K, Ohkuwa K, Kitagawa W, Nagahama M, Ito K. PMID: 34353305.
      View in: PubMed   Mentions:    Fields:    
    3. Risk stratification in differentiated thyroid cancer with RAI-avid lung metastases. Endocr Connect. 2021 Jul 26; 10(8):825-833. Ohkuwa K, Sugino K, Nagahama M, Kitagawa W, Matsuzu K, Suzuki A, Tomoda C, Hames K, Akaishi J, Masaki C, Ito K. PMID: 34223823.
      View in: PubMed   Mentions:
    4. Does Age or Sex Relate to Severity or Treatment Prognosis in Graves' Disease? Thyroid. 2021 09; 31(9):1409-1415. Suzuki N, Noh JY, Yoshimura R, Mikura K, Kinoshita A, Suzuki A, Mitsumatsu T, Hoshiyama A, Fukushita M, Matsumoto M, Yoshihara A, Watanabe N, Sugino K, Ito K. PMID: 33882721.
      View in: PubMed   Mentions:    Fields:    
    5. A case of macro-TSH consisting of IgA-bound TSH. Endocr J. 2021 May 25. Fukushita M, Watanabe N, Yoshimura Noh J, Yoshihara A, Matsumoto M, Suzuki N, Yoshimura R, Sugino K, Ito K. PMID: 34039782.
      View in: PubMed   Mentions:    Fields:    
    6. The Time Series Behavior of Neutrophil-to-Lymphocyte Ratio in Thyroid Cancer Patients on Tyrosine Kinase Inhibitor Therapy. ORL J Otorhinolaryngol Relat Spec. 2021; 83(5):347-353. Tomoda C, Sugino K, Kitagawa W, Nagahama M, Ito K. PMID: 33735904.
      View in: PubMed   Mentions:    Fields:    
    7. Clinical Course of Euthyroid Subjects With Positive TSH Receptor Antibody: How Often Does Graves' Disease Develop? J Endocr Soc. 2021 Jun 01; 5(6):bvab042. Suzuki N, Kawaguchi A, Yoshimura Noh J, Yoshimura R, Mikura K, Kinoshita A, Suzuki A, Mitsumatsu T, Hoshiyama A, Fukushita M, Matsumoto M, Yoshihara A, Watanabe N, Sugino K, Ito K. PMID: 34017933.
      View in: PubMed   Mentions:
    8. Exposure to Propylthiouracil in the First Trimester of Pregnancy and Birth Defects: A Study at a Single Institution. J Endocr Soc. 2021 Mar 01; 5(3):bvaa204. Yoshihara A, Noh JY, Watanabe N, Fukushita M, Matsumoto M, Suzuki N, Hoshiyama A, Suzuki A, Mitsumatsu T, Kinoshita A, Mikura K, Yoshimura R, Sugino K, Ito K. PMID: 33506163.
      View in: PubMed   Mentions:
    9. Clinical management of low-risk papillary thyroid microcarcinoma. Minerva Endocrinol. 2021 Jan 12. Masaki C, Sugino K, Ito K. PMID: 33435642.
      View in: PubMed   Mentions:    Fields:    
    10. Outcomes for Minimally Invasive Follicular Thyroid Carcinoma in Relation to the Change in Age Stratification in the AJCC 8th Edition. Ann Surg Oncol. 2021 Jul; 28(7):3576-3583. Yamazaki H, Sugino K, Katoh R, Matsuzu K, Masaki C, Akaishi J, Yamada Hames K, Tomoda C, Suzuki A, Ohkuwa K, Kitagawa W, Nagahama M, Masuda M, Ito K. PMID: 33237449.
      View in: PubMed   Mentions:    Fields:    Translation:Humans
    11. ASO Author Reflections: Outcomes for Minimally Invasive Follicular Thyroid Carcinoma in AJCC 8th Edition. Ann Surg Oncol. 2021 Jul; 28(7):3584. Yamazaki H, Sugino K, Katoh R, Matsuzu K, Masuda M, Ito K. PMID: 33225393.
      View in: PubMed   Mentions:    Fields:    Translation:Humans
    12. Distant Metastasis in Pediatric and Adolescent Differentiated Thyroid Cancer: Clinical Outcomes and Risk Factor Analyses. J Clin Endocrinol Metab. 2020 11 01; 105(11). Sugino K, Nagahama M, Kitagawa W, Ohkuwa K, Uruno T, Matsuzu K, Suzuki A, Tomoda C, Hames KY, Akaishi J, Masaki C, Ito K. PMID: 32813019.
      View in: PubMed   Mentions: 4     Fields:    Translation:Humans
    13. Propylthiouracil-induced otitis media with anti-neutrophil cytoplasmic antibody-associated vasculitis: a case report and review of the literature. Endocr J. 2021 Feb 28; 68(2):145-151. Hiruma M, Sasano Y, Watanabe N, Yoshihara A, Ishii S, Yaguchi Y, Yoshimura Noh J, Sugino K, Ito K. PMID: 32999132.
      View in: PubMed   Mentions:    Fields:    
    14. TRAb elevations occurred even in the third trimester; a case of a mother of a child with neonatal thyroid dysfunction, who received radioactive iodine therapy for Graves' disease. Endocr J. 2020 Oct 28; 67(10):1019-1022. Suzuki N, Yoshihara A, Yoshimura Noh J, Kinoshita K, Ohnishi J, Saito M, Sugino K, Ito K. PMID: 32522908.
      View in: PubMed   Mentions:    Fields:    Translation:Humans
    15. Clinical outcomes and risk stratification for papillary thyroid carcinoma presenting with distant metastasis before the era of tyrosine kinase inhibitors. Endocr J. 2020 Aug 28; 67(8):869-876. Matsuzu K, Sugino K, Masudo K, Mori K, Ono R, Yamazaki H, Masaki C, Akaishi J, Kiyomi Yamada H, Tomoda C, Suzuki A, Uruno T, Ohkuwa K, Kitagawa W, Nagahama M, Takami H, Ito K. PMID: 32350192.
      View in: PubMed   Mentions:    Fields:    Translation:Humans
    16. Urinalysis by combination of the dipstick test and urine protein-creatinine ratio (UPCR) assessment can prevent unnecessary lenvatinib interruption in patients with thyroid cancer. Int J Clin Oncol. 2020 Jul; 25(7):1278-1284. Masaki C, Sugino K, Kobayashi S, Akaishi J, Hames KY, Tomoda C, Suzuki A, Matsuzu K, Uruno T, Ohkuwa K, Kitagawa W, Nagahama M, Ito K. PMID: 32347432.
      View in: PubMed   Mentions: 3     Fields:    Translation:Humans
    17. Inflammatory biomarkers and dynamics of neutrophil-to-lymphocyte ratio in anaplastic thyroid carcinoma. Endocrine. 2020 10; 70(1):115-122. Yamazaki H, Sugino K, Matsuzu K, Masaki C, Akaishi J, Hames K, Tomoda C, Suzuki A, Uruno T, Ohkuwa K, Kitagawa W, Nagahama M, Masuda M, Ito K. PMID: 32307657.
      View in: PubMed   Mentions: 5     Fields:    Translation:HumansCells
    18. Therapeutic efficacy and limitations of potassium iodide for patients newly diagnosed with Graves' disease. Endocr J. 2020 Jun 29; 67(6):631-638. Suzuki N, Yoshimura Noh J, Sugisawa C, Hoshiyama A, Hiruma M, Kawaguchi A, Morisaki M, Ohye H, Suzuki M, Matsumoto M, Kunii Y, Yoshihara A, Watanabe N, Sugino K, Ito K. PMID: 32188795.
      View in: PubMed   Mentions:    Fields:    Translation:HumansCTClinical Trials
    19. Risk Stratification of Pediatric Patients with Differentiated Thyroid Cancer: Is Total Thyroidectomy Necessary for Patients at Any Risk? Thyroid. 2020 04; 30(4):548-556. Sugino K, Nagahama M, Kitagawa W, Ohkuwa K, Uruno T, Matsuzu K, Suzuki A, Tomoda C, Hames KY, Akaishi J, Masaki C, Ito K. PMID: 31910105.
      View in: PubMed   Mentions: 7     Fields:    Translation:Humans
    20. Rapid disease progression after discontinuation of lenvatinib in thyroid cancer. Medicine (Baltimore). 2020 Mar; 99(11):e19408. Yamazaki H, Sugino K, Matsuzu K, Masaki C, Akaishi J, Hames K, Tomoda C, Suzuki A, Uruno T, Ohkuwa K, Kitagawa W, Nagahama M, Masuda M, Ito K. PMID: 32176066.
      View in: PubMed   Mentions:    Fields:    Translation:Humans
    21. Characteristics of Patients with Graves' Disease Whose Thyroid Hormone Levels Increase After Substituting Potassium Iodide for Methimazole in the First Trimester of Pregnancy. Thyroid. 2020 03; 30(3):451-456. Yoshihara A, Noh JY, Watanabe N, Kunii Y, Suzuki M, Matsumoto M, Suzuki N, Hiruma M, Morisaki M, Kawaguchi A, Sugino K, Ito K. PMID: 31928169.
      View in: PubMed   Mentions: 1     Fields:    Translation:Humans
    22. Efficacy and Limitations of Lenvatinib Therapy for Radioiodine-Refractory Differentiated Thyroid Cancer: Real-World Experiences. Thyroid. 2020 02; 30(2):214-221. Masaki C, Sugino K, Saito N, Akaishi J, Hames KY, Tomoda C, Suzuki A, Matsuzu K, Uruno T, Ohkuwa K, Kitagawa W, Nagahama M, Ito K. PMID: 31854270.
      View in: PubMed   Mentions: 5     Fields:    Translation:Humans
    23. Sarcopenia is a prognostic factor for TKIs in metastatic thyroid carcinomas. Endocrine. 2020 04; 68(1):132-137. Yamazaki H, Sugino K, Matsuzu K, Masaki C, Akaishi J, Hames K, Tomoda C, Suzuki A, Uruno T, Ohkuwa K, Kitagawa W, Nagahama M, Masuda M, Ito K. PMID: 31865555.
      View in: PubMed   Mentions: 2     Fields:    Translation:Humans
    24. Stereotactic radiotherapy using the CyberKnife is effective for local control of bone metastases from differentiated thyroid cancer. J Radiat Res. 2019 Nov 22; 60(6):831-836. Ishigaki T, Uruno T, Sugino K, Masaki C, Akaishi J, Hames KY, Suzuki A, Tomoda C, Matsuzu K, Ohkuwa K, Kitagawa W, Nagahama M, Miyazaki S, Ito K. PMID: 31423531.
      View in: PubMed   Mentions: 3     Fields:    Translation:Humans
    25. Analysis of Antithyroid Drug-Induced Severe Liver Injury in 18,558 Newly Diagnosed Patients with Graves' Disease in Japan. Thyroid. 2019 10; 29(10):1390-1398. Suzuki N, Noh JY, Hiruma M, Kawaguchi A, Morisaki M, Ohye H, Suzuki M, Matsumoto M, Kunii Y, Iwaku K, Yoshihara A, Watanabe N, Sugino K, Ito K. PMID: 31573408.
      View in: PubMed   Mentions: 3     Fields:    Translation:Humans
    26. Prognostic Impact of the Turin Criteria in Poorly Differentiated Thyroid Carcinoma. World J Surg. 2019 09; 43(9):2235-2244. Akaishi J, Kondo T, Sugino K, Ogimi Y, Masaki C, Hames KY, Yabuta T, Tomoda C, Suzuki A, Matsuzu K, Uruno T, Ohkuwa K, Kitagawa W, Nagahama M, Katoh R, Ito K. PMID: 31098668.
      View in: PubMed   Mentions: 4     Fields:    Translation:Humans
    27. The impact of completion thyroidectomy followed by radioactive iodine ablation for patients with lymph node recurrence of papillary thyroid carcinoma. Surgery. 2019 09; 166(3):342-348. Saito Y, Matsuzu K, Sugino K, Takami H, Kitagawa W, Nagahama M, Ito K. PMID: 31128851.
      View in: PubMed   Mentions:    Fields:    Translation:Humans
    28. Influence of CYP3A4/5 and ABC transporter polymorphisms on lenvatinib plasma trough concentrations in Japanese patients with thyroid cancer. Sci Rep. 2019 04 01; 9(1):5404. Ozeki T, Nagahama M, Fujita K, Suzuki A, Sugino K, Ito K, Miura M. PMID: 30931962.
      View in: PubMed   Mentions: 3     Fields:    Translation:Humans
    29. Association of lenvatinib trough plasma concentrations with lenvatinib-induced toxicities in Japanese patients with thyroid cancer. Med Oncol. 2019 Mar 27; 36(5):39. Nagahama M, Ozeki T, Suzuki A, Sugino K, Niioka T, Ito K, Miura M. PMID: 30919115.
      View in: PubMed   Mentions: 6     Fields:    Translation:Humans
    30. Usefulness of Stereotactic Radiotherapy Using the CyberKnife for Patients with Inoperable Locoregional Recurrences of Differentiated Thyroid Cancer. World J Surg. 2019 Feb; 43(2):513-518. Ishigaki T, Uruno T, Tanaka T, Ogimi Y, Masaki C, Akaishi J, Hames KY, Yabuta T, Suzuki A, Tomoda C, Matsuzu K, Ohkuwa K, Kitagawa W, Nagahama M, Sugino K, Ito K. PMID: 30267291.
      View in: PubMed   Mentions: 4     Fields:    Translation:Humans
    31. Change of surgical strategy for Graves' disease from subtotal thyroidectomy to total thyroidectomy: a single institutional experience. Endocr J. 2019 Feb 28; 66(2):181-186. Sugino K, Nagahama M, Kitagawa W, Ohkuwa K, Uruno T, Matsuzu K, Suzuki A, Tomoda C, Y Hames K, Akaishi J, Masaki C, Ogimi Y, Yabuta T, Ito K. PMID: 30568070.
      View in: PubMed   Mentions: 1     Fields:    Translation:Humans
    32. Incidence of Neonatal Hyperthyroidism Among Newborns of Graves' Disease Patients Treated with Radioiodine Therapy. Thyroid. 2019 01; 29(1):128-134. Yoshihara A, Iwaku K, Noh JY, Watanabe N, Kunii Y, Ohye H, Suzuki M, Matsumoto M, Suzuki N, Tadokoro R, Sekiyama C, Hiruma M, Sugino K, Ito K. PMID: 30426886.
      View in: PubMed   Mentions: 4     Fields:    Translation:Humans
    33. Cribriform-Morular Variant of Papillary Thyroid Carcinoma: Clinical and Pathological Features of 30 Cases. World J Surg. 2018 11; 42(11):3616-3623. Akaishi J, Kondo T, Sugino K, Ogimi Y, Masaki C, Hames KY, Yabuta T, Tomoda C, Suzuki A, Matsuzu K, Uruno T, Ohkuwa K, Kitagawa W, Nagahama M, Katoh R, Ito K. PMID: 29696324.
      View in: PubMed   Mentions: 3     Fields:    Translation:Humans
    34. Clinical Status and Treatment of Liver Metastasis of Differentiated Thyroid Cancer Using Tyrosine Kinase Inhibitors. World J Surg. 2018 11; 42(11):3632-3637. Saito Y, Sugino K, Takami H, Matsuzu K, Uruno T, Ohkuwa K, Kitagawa W, Nagahama M, Kawakubo H, Ito K, Kitagawa Y. PMID: 29766229.
      View in: PubMed   Mentions: 3     Fields:    Translation:Humans
    35. Cohort study exploring the effect of lenvatinib on differentiated thyroid cancer. Endocr J. 2018 Nov 29; 65(11):1071-1074. Tahara M, Takami H, Ito Y, Sugino K, Takahashi S, Takeyama H, Tsutsui H, Hara H, Mitsuma A, Yamashita H, Okamoto T, Sugitani I, Ohashi Y, Imai T. PMID: 30369531.
      View in: PubMed   Mentions:    Fields:    Translation:Humans
    36. Rapid Growth and Early Metastasis of Papillary Thyroid Carcinoma in an Adolescent Girl with Graves' Disease. Horm Res Paediatr. 2019; 91(3):210-215. Shimura K, Shibata H, Mizuno Y, Amano N, Hoshino K, Kuroda T, Kameyama K, Matsuse M, Mitsutake N, Sugino K, Yoshimura Noh J, Hasegawa T, Ishii T. PMID: 30092570.
      View in: PubMed   Mentions:    Fields:    Translation:Humans
    37. Re: "High Thyroid Cancer Mortality Rate in Japan: A Result of Nonaggressive Treatment Strategy, or Just an Aging Population?" By Magner (Thyroid 2018;28:818-819). Thyroid. 2018 06; 28(6):820-822. Davies L, Sugino K, Sugitani I, Tomoda C. PMID: 29644937.
      View in: PubMed   Mentions: 1     Fields:    Translation:Humans
    38. Clinical course of thyroid function and thyroid associated-ophthalmopathy in patients with euthyroid Graves' disease. Clin Ophthalmol. 2018; 12:739-746. Suzuki N, Noh JY, Kameda T, Yoshihara A, Ohye H, Suzuki M, Matsumoto M, Kunii Y, Iwaku K, Watanabe N, Mukasa K, Kozaki A, Inoue T, Sugino K, Ito K. PMID: 29719374.
      View in: PubMed   Mentions:
    39. Seasonal Changes in Serum Thyrotropin Concentrations Observed from Big Data Obtained During Six Consecutive Years from 2010 to 2015 at a Single Hospital in Japan. Thyroid. 2018 04; 28(4):429-436. Yoshihara A, Noh JY, Watanabe N, Iwaku K, Kunii Y, Ohye H, Suzuki M, Matsumoto M, Suzuki N, Sugino K, Thienpont LM, Hishinuma A, Ito K. PMID: 29608438.
      View in: PubMed   Mentions: 9     Fields:    Translation:Humans
    40. Long-Term Outcomes of 107 Cases of Primary Thyroid Mucosa-Associated Lymphoid Tissue Lymphoma at a Single Medical Institution in Japan. J Clin Endocrinol Metab. 2018 02 01; 103(2):732-739. Watanabe N, Narimatsu H, Noh JY, Iwaku K, Kunii Y, Suzuki N, Ohye H, Suzuki M, Matsumoto M, Yoshihara A, Kameyama K, Kobayashi K, Kami M, Sugino K, Ito K. PMID: 29165612.
      View in: PubMed   Mentions: 3     Fields:    Translation:Humans
    41. Globus Symptoms in Patients Undergoing Thyroidectomy: Relationships with Psychogenic Factors, Thyroid Disease, and Surgical Procedure. Thyroid. 2018 01; 28(1):104-109. Tomoda C, Sugino K, Tanaka T, Ogimi Y, Masaki C, Akaishi J, Hames KY, Suzuki A, Matsuzu K, Uruno T, Ohkuwa K, Kitagawa W, Nagahama M, Ito K. PMID: 29183262.
      View in: PubMed   Mentions: 1     Fields:    Translation:Humans
    42. EZH2 Overexpression as a Useful Prognostic Marker for Aggressive Behaviour in Thyroid Cancer. In Vivo. 2018 Jan-Feb; 32(1):25-31. Masudo K, Suganuma N, Nakayama H, Oshima T, Rino Y, Iwasaki H, Matsuzu K, Sugino K, Ito K, Kondo T, Nakamura Y, Yoshihara M, Masuda M, Miyagi Y. PMID: 29275295.
      View in: PubMed   Mentions: 11     Fields:    Translation:Humans
    43. Clinical factors related to the efficacy of tyrosine kinase inhibitor therapy in radioactive iodine refractory recurrent differentiated thyroid cancer patients. Endocr J. 2018 Mar 28; 65(3):299-306. Sugino K, Nagahama M, Kitagawa W, Ohkuwa K, Uruno T, Matsuzu K, Suzuki A, Masaki C, Akaishi J, Hames KY, Tomoda C, Ogimi Y, Ito K. PMID: 29269689.
      View in: PubMed   Mentions: 5     Fields:    Translation:Humans
    44. Lenvatinib induces early tumor shrinkage in patients with advanced thyroid carcinoma. Endocr J. 2017 Aug 30; 64(8):819-826. Masaki C, Sugino K, Saito N, Saito Y, Tanaka T, Ogimi Y, Maeda T, Osaku T, Akaishi J, Hames KY, Tomoda C, Suzuki A, Matsuzu K, Uruno T, Ohkuwa K, Kitagawa W, Nagahama M, Takami H, Ito K. PMID: 28659544.
      View in: PubMed   Mentions: 5     Fields:    Translation:Humans
    45. A case of familial dysalbuminemic hyperthyroxinemia (FDH) in Japan: FDH as a possible differential diagnosis of syndrome of inappropriate secretion of thyroid-stimulating hormone (SITSH). Endocr J. 2017 Feb 27; 64(2):207-212. Kobayashi S, Yoshimura Noh J, Shimizu T, Sato T, Kurihara I, Sugino K, Itoh H, Ito K. PMID: 27904073.
      View in: PubMed   Mentions: 4     Fields:    Translation:Humans
    46. Outpatient 131I Treatment for a Patient with Graves' Disease Receiving Hemodialysis. Intern Med. 2016; 55(22):3309-3313. Suzuki M, Yoshimura Noh J, Sugino K, Ito K. PMID: 27853074.
      View in: PubMed   Mentions: 1     Fields:    Translation:Humans
    47. Cervical Lymph Node Metastases After Thyroidectomy for Papillary Thyroid Carcinoma Usually Remain Stable for Years. Thyroid. 2016 12; 26(12):1706-1711. Tomoda C, Sugino K, Matsuzu K, Uruno T, Ohkuwa K, Kitagawa W, Nagahama M, Ito K. PMID: 27616725.
      View in: PubMed   Mentions: 1     Fields:    Translation:Humans
    48. The characteristics of osteoporotic patients in Graves' disease patients newly diagnosed after menopause: a prospective observational study. Endocr J. 2016 Dec 30; 63(12):1113-1122. Yoshihara A, Yoshimura Noh J, Mukasa K, Watanabe N, Iwaku K, Ohye H, Suzuki M, Matsumoto M, Kunii Y, Suzuki N, Endo K, Suzuki R, Hattori N, Sugino K, Ito K. PMID: 27600197.
      View in: PubMed   Mentions: 1     Fields:    Translation:Humans
    49. The Safety and Efficacy of Weekly Paclitaxel Administration for Anaplastic Thyroid Cancer Patients: A Nationwide Prospective Study. Thyroid. 2016 09; 26(9):1293-9. Onoda N, Sugino K, Higashiyama T, Kammori M, Toda K, Ito K, Yoshida A, Suganuma N, Nakashima N, Suzuki S, Tsukahara K, Noguchi H, Koizumi M, Nemoto T, Hara H, Miyauchi A, Sugitani I. PMID: 27484330.
      View in: PubMed   Mentions: 9     Fields:    Translation:HumansCTClinical Trials
    50. Tyrosine-kinase inhibitors to treat radioiodine-refracted, metastatic, or recurred and progressive differentiated thyroid carcinoma [Review]. Endocr J. 2016 Jul 30; 63(7):597-602. Ito Y, Suzuki S, Ito K, Imai T, Okamoto T, Kitano H, Sugitani I, Sugino K, Tsutsui H, Hara H, Yoshida A, Shimizu K. PMID: 27210070.
      View in: PubMed   Mentions: 6     Fields:    Translation:Humans
    51. Prognosis After Brain Metastasis from Differentiated Thyroid Carcinoma. World J Surg. 2016 Mar; 40(3):574-81. Saito F, Uruno T, Shibuya H, Kitagawa W, Nagahama M, Sugino K, Ito K. PMID: 26762631.
      View in: PubMed   Mentions: 2     Fields:    Translation:Humans
    52. Histopathological analysis of anaplastic thyroid carcinoma cases with long-term survival: A report from the Anaplastic Thyroid Carcinoma Research Consortium of Japan. Endocr J. 2016 May 31; 63(5):441-7. Hirokawa M, Sugitani I, Kakudo K, Sakamoto A, Higashiyama T, Sugino K, Toda K, Ogasawara S, Yoshimoto S, Hasegawa Y, Imai T, Onoda N, Orita Y, Kammori M, Fujimori K, Yamada H. PMID: 26842589.
      View in: PubMed   Mentions: 7     Fields:    Translation:Humans
    53. Outcome and characteristics of patients with malignant pleural effusion from differentiated thyroid carcinoma. Endocr J. 2016; 63(3):257-61. Tomoda C, Ogimi Y, Saito F, Masaki C, Akaishi J, Matsuzu K, Suzuki A, Uruno T, Ohkuwa K, Shibuya H, Kitagawa W, Nagahama M, Sugino K, Ito K. PMID: 26655349.
      View in: PubMed   Mentions: 4     Fields:    Translation:Humans
    54. Pathological Findings of the Thyroid Tissue in a Patient with Euthyroid Graves' Disease. Intern Med. 2015; 54(22):2881-4. Suzuki N, Yoshihara A, Yoshimura Noh J, Kozaki A, Inoue T, Sugino K, Ito K. PMID: 26568003.
      View in: PubMed   Mentions: 2     Fields:    Translation:Humans
    55. Inhibitory effect of low-dose inorganic iodine on thyroidal radioactive iodine uptake in healthy Japanese adults. Endocr J. 2016; 63(1):21-7. Kunii Y, Uruno T, Mukasa K, Sekiya K, Iwaku K, Suzuki A, Sugino K, Yoshimura Noh J, Ito K. PMID: 26560237.
      View in: PubMed   Mentions: 3     Fields:    Translation:HumansCellsCTClinical Trials
    56. Papillary Thyroid Carcinoma in Children and Adolescents: Long-Term Follow-Up and Clinical Characteristics. World J Surg. 2015 Sep; 39(9):2259-65. Sugino K, Nagahama M, Kitagawa W, Shibuya H, Ohkuwa K, Uruno T, Suzuki A, Akaishi J, Masaki C, Matsuzu K, Ito K. PMID: 25802237.
      View in: PubMed   Mentions: 8     Fields:    Translation:Humans
    57. Substituting Potassium Iodide for Methimazole as the Treatment for Graves' Disease During the First Trimester May Reduce the Incidence of Congenital Anomalies: A Retrospective Study at a Single Medical Institution in Japan. Thyroid. 2015 Oct; 25(10):1155-61. Yoshihara A, Noh JY, Watanabe N, Mukasa K, Ohye H, Suzuki M, Matsumoto M, Kunii Y, Suzuki N, Kameda T, Iwaku K, Kobayashi S, Sugino K, Ito K. PMID: 26222916.
      View in: PubMed   Mentions: 7     Fields:    Translation:Humans
    58. Clinicopathologic features and outcomes in patients with diffuse sclerosing variant of papillary thyroid carcinoma. World J Surg. 2015 Jul; 39(7):1728-35. Akaishi J, Sugino K, Kameyama K, Masaki C, Matsuzu K, Suzuki A, Uruno T, Ohkuwa K, Shibuya H, Kitagawa W, Nagahama M, Shimizu K, Ito K. PMID: 25743484.
      View in: PubMed   Mentions: 6     Fields:    Translation:Humans
    59. Concept and design of a nationwide prospective feasibility/efficacy/safety study of weekly paclitaxel for patients with pathologically confirmed anaplastic thyroid cancer (ATCCJ-PTX-P2). BMC Cancer. 2015 Jun 20; 15:475. Onoda N, Sugitani I, Higashiyama T, Hara H, Ito K, Kammori M, Sugino K, Suzuki S, Toda K, Yoshida A, Miyauchi A. PMID: 26091846.
      View in: PubMed   Mentions: 3     Fields:    Translation:HumansCTClinical Trials
    60. Radioiodine-Associated Exacerbation of Graves' Orbitopathy in the Japanese Population: Randomized Prospective Study. J Clin Endocrinol Metab. 2015 Jul; 100(7):2700-8. Watanabe N, Noh JY, Kozaki A, Iwaku K, Sekiya K, Kosuga Y, Matsumoto M, Suzuki M, Yoshihara A, Ohye H, Kobayashi S, Kunii Y, Mukasa K, Sugino K, Inoue T, Ito K. PMID: 25965082.
      View in: PubMed   Mentions: 7     Fields:    Translation:HumansPHPublic Health
    61. Antimicrobial prophylaxis for the prevention of surgical site infection after thyroid and parathyroid surgery: a prospective randomized trial. World J Surg. 2015 May; 39(5):1282-7. Uruno T, Masaki C, Suzuki A, Ohkuwa K, Shibuya H, Kitagawa W, Nagahama M, Sugino K, Ito K. PMID: 25566977.
      View in: PubMed   Mentions: 3     Fields:    Translation:Humans
    62. Serum human chorionic gonadotropin levels and thyroid hormone levels in gestational transient thyrotoxicosis: Is the serum hCG level useful for differentiating between active Graves' disease and GTT? Endocr J. 2015; 62(6):557-60. Yoshihara A, Noh JY, Mukasa K, Suzuki M, Ohye H, Matsumoto M, Kunii Y, Watanabe N, Suzuki N, Kameda T, Sugino K, Ito K. PMID: 25819223.
      View in: PubMed   Mentions: 4     Fields:    Translation:Humans
    63. Chemosensitivity of anaplastic thyroid cancer based on a histoculture drug response assay. Int J Endocrinol. 2015; 2015:967286. Uruno T, Masaki C, Akaishi J, Matsuzu K, Suzuki A, Ohkuwa K, Shibuya H, Kitagawa W, Nagahama M, Sugino K, Ito K. PMID: 25866510.
      View in: PubMed   Mentions:
    64. Comparison of efficacy and adverse effects between methimazole 15 mg+inorganic iodine 38 mg/day and methimazole 30 mg/day as initial therapy for Graves' disease patients with moderate to severe hyperthyroidism. Thyroid. 2015 Jan; 25(1):43-50. Hanna RF, Ward TJ, Chow DS, Lagana SM, Moreira RK, Emond JC, Weintraub JL, Prince MR, Sato S, Noh JY, Sato S, Suzuki M, Yasuda S, Matsumoto M, Kunii Y, Mukasa K, Sugino K, Ito K, Nagataki S, Taniyama M. PMID: 25178068.
      View in: PubMed   Mentions: 9     Fields:    Translation:HumansCTClinical Trials
    65. Anaplastic thyroid carcinomas incidentally found on postoperative pathological examination. World J Surg. 2014 Sep; 38(9):2311-6. Yoshida A, Sugino K, Sugitani I, Miyauchi A. PMID: 24687351.
      View in: PubMed   Mentions: 6     Fields:    Translation:Humans
    66. Changes in pediatric thyroid sonograms in or nearby the Kanto region before and after the accident at the Fukushima Daiichi nuclear power plant. Endocr J. 2014; 61(9):875-81. Iwaku K, Noh JY, Sasaki E, Suzuki N, Kameda T, Kobayashi S, Yoshihara A, Ohye H, Watanabe N, Suzuki M, Matsumoto M, Kunii Y, Mukasa K, Sugino K, Ito K. PMID: 25008050.
      View in: PubMed   Mentions: 1     Fields:    Translation:Humans
    67. Development of molecular targeted drugs for advanced thyroid cancer in Japan. Endocr J. 2014; 61(9):833-9. Takami H, Ito K, Sugino K. PMID: 24849385.
      View in: PubMed   Mentions: 2     Fields:    Translation:Humans
    68. Rituximab-including combined modality treatment for primary thyroid lymphoma: an effective regimen for elderly patients. Thyroid. 2014 Jun; 24(6):994-9. Watanabe N, Narimatsu H, Noh JY, Kunii Y, Mukasa K, Matsumoto M, Suzuki M, Sekiya K, Ohye H, Yoshihara A, Iwaku K, Kobayashi S, Kobayashi S, Kameyama K, Kobayashi K, Nishikawa Y, Kami M, Sugino K, Ito K. PMID: 24547778.
      View in: PubMed   Mentions: 3     Fields:    Translation:Humans
    69. Does completion thyroidectomy improve the outcome of patients with minimally invasive follicular carcinoma of the thyroid? Ann Surg Oncol. 2014 Sep; 21(9):2981-6. Sugino K, Kameyama K, Nagahama M, Kitagawa W, Shibuya H, Ohkuwa K, Uruno T, Akaishi J, Suzuki A, Masaki C, Matsuzu K, Kawano M, Ito K. PMID: 24770681.
      View in: PubMed   Mentions: 8     Fields:    Translation:Humans
    70. Optimal timing of surgery for differentiated thyroid cancer in pregnant women. World J Surg. 2014 Mar; 38(3):704-8. Uruno T, Shibuya H, Kitagawa W, Nagahama M, Sugino K, Ito K. PMID: 24248429.
      View in: PubMed   Mentions: 5     Fields:    Translation:Humans
    71. Characteristics of agranulocytosis as an adverse effect of antithyroid drugs in the second or later course of treatment. Thyroid. 2014 May; 24(5):796-801. Kobayashi S, Noh JY, Mukasa K, Kunii Y, Watanabe N, Matsumoto M, Ohye H, Suzuki M, Yoshihara A, Iwaku K, Sugino K, Ito K. PMID: 24341564.
      View in: PubMed   Mentions: 7     Fields:    Translation:HumansCells
    72. Follicular thyroid carcinoma with distant metastasis: outcome and prognostic factor. Endocr J. 2014; 61(3):273-9. Sugino K, Kameyama K, Nagahama M, Kitagawa W, Shibuya H, Ohkuwa K, Uruno T, Akaishi J, Suzuki A, Masaki C, Matsuzu K, Kawano M, Ito K. PMID: 24420337.
      View in: PubMed   Mentions: 4     Fields:    Translation:Humans
    73. Frequency of Adverse Events of Antithyroid Drugs Administered during Pregnancy. J Thyroid Res. 2014; 2014:952352. Yoshihara A, Noh JY, Watanabe N, Iwaku K, Kobayashi S, Suzuki M, Ohye H, Matsumoto M, Kunii Y, Mukasa K, Sugino K, Ito K. PMID: 24523983.
      View in: PubMed   Mentions:
    74. Thyroid lobectomy for papillary thyroid cancer: long-term follow-up study of 1,088 cases. World J Surg. 2014 Jan; 38(1):68-79. Matsuzu K, Sugino K, Masudo K, Nagahama M, Kitagawa W, Shibuya H, Ohkuwa K, Uruno T, Suzuki A, Magoshi S, Akaishi J, Masaki C, Kawano M, Suganuma N, Rino Y, Masuda M, Kameyama K, Takami H, Ito K. PMID: 24081532.
      View in: PubMed   Mentions: 51     Fields:    Translation:Humans
    75. Does Hürthle cell carcinoma of the thyroid have a poorer prognosis than ordinary follicular thyroid carcinoma? Ann Surg Oncol. 2013 Sep; 20(9):2944-50. Sugino K, Kameyama K, Ito K, Nagahama M, Kitagawa W, Shibuya H, Ohkuwa K, Uruno T, Akaishi J, Suzuki A, Masaki C, Ito K. PMID: 23616135.
      View in: PubMed   Mentions: 14     Fields:    Translation:Humans
    76. Diagnostic accuracy of fine needle aspiration biopsy cytology and ultrasonography in patients with thyroid nodules diagnosed as benign or indeterminate before thyroidectomy. Endocr J. 2013; 60(3):375-82. Sugino K, Ito K, Nagahama M, Kitagawa W, Shibuya H, Ohkuwa K, Yano Y, Uruno T, Akaishi J, Suzuki A, Masaki C, Ito K. PMID: 23197046.
      View in: PubMed   Mentions: 9     Fields:    Translation:Humans
    77. Serum intact parathyroid hormone level after total thyroidectomy or total thyroidectomy plus lymph node dissection for thyroid nodules: report from 296 surgical cases. Int J Endocrinol Metab. 2012; 10(4):594-8. Yano Y, Masaki C, Sugino K, Nagahama M, Kitagawa W, Sibuya H, Ito K. PMID: 23843829.
      View in: PubMed   Mentions:
    78. Changes in the thyroid function of Graves' disease patients treated by subtotal thyroidectomy. Endocr J. 2012; 59(12):1115-20. Sugino K, Ito K, Nagahama M, Kitagawa W, Shibuya H, Ohkuwa K, Yano Y, Uruno T, Akaishi J, Suzuki A, Masaki C, Ito K. PMID: 22971989.
      View in: PubMed   Mentions: 1     Fields:    Translation:Humans
    79. Outcomes and prognostic factors of 251 patients with minimally invasive follicular thyroid carcinoma. Thyroid. 2012 Aug; 22(8):798-804. Sugino K, Kameyama K, Ito K, Nagahama M, Kitagawa W, Shibuya H, Ohkuwa K, Yano Y, Uruno T, Akaishi J, Suzuki A, Masaki C, Ito K. PMID: 22853727.
      View in: PubMed   Mentions: 18     Fields:    Translation:Humans
    80. Prognostic factors and treatment outcomes for anaplastic thyroid carcinoma: ATC Research Consortium of Japan cohort study of 677 patients. World J Surg. 2012 Jun; 36(6):1247-54. Sugitani I, Miyauchi A, Sugino K, Okamoto T, Yoshida A, Suzuki S. PMID: 22311136.
      View in: PubMed   Mentions: 70     Fields:    Translation:Humans
    81. Treatment of autonomously functioning thyroid nodules at a single institution: radioiodine therapy, surgery, and ethanol injection therapy. Ann Nucl Med. 2011 Dec; 25(10):749-54. Yano Y, Sugino K, Akaishi J, Uruno T, Okuwa K, Shibuya H, Kitagawa W, Nagahama M, Ito K, Ito K. PMID: 21971604.
      View in: PubMed   Mentions: 1     Fields:    Translation:Humans
    82. Prognostic factors and treatment outcomes of 100 cases of anaplastic thyroid carcinoma. Thyroid. 2011 Nov; 21(11):1183-9. Akaishi J, Sugino K, Kitagawa W, Nagahama M, Kameyama K, Shimizu K, Ito K, Ito K. PMID: 21936674.
      View in: PubMed   Mentions: 43     Fields:    Translation:Humans
    83. Prognosis and prognostic factors for distant metastases and tumor mortality in follicular thyroid carcinoma. Thyroid. 2011 Jul; 21(7):751-7. Sugino K, Ito K, Nagahama M, Kitagawa W, Shibuya H, Ohkuwa K, Yano Y, Uruno T, Akaishi J, Kameyama K, Ito K. PMID: 21615311.
      View in: PubMed   Mentions: 26     Fields:    Translation:Humans
    84. Minimally invasive surgery for primary hyperparathyroidism with or without intraoperative parathyroid hormone monitoring. Endocr J. 2010; 57(11):953-8. Sugino K, Ito K, Nagahama M, Kitagawa W, Shibuya H, Ohkuwa K, Yano Y, Ito K. PMID: 20823623.
      View in: PubMed   Mentions: 7     Fields:    Translation:Humans
    85. Treatment strategy of papillary thyroid carcinoma in children and adolescents: clinical significance of the initial nodal manifestation. Ann Surg Oncol. 2009 Dec; 16(12):3442-9. Wada N, Sugino K, Mimura T, Nagahama M, Kitagawa W, Shibuya H, Ohkuwa K, Nakayama H, Hirakawa S, Yukawa N, Rino Y, Masuda M, Ito K. PMID: 19777194.
      View in: PubMed   Mentions: 14     Fields:    Translation:Humans
    86. Pediatric differentiated thyroid carcinoma in stage I: risk factor analysis for disease free survival. BMC Cancer. 2009 Sep 01; 9:306. Wada N, Sugino K, Mimura T, Nagahama M, Kitagawa W, Shibuya H, Ohkuwa K, Nakayama H, Hirakawa S, Rino Y, Masuda M, Ito K. PMID: 19723317.
      View in: PubMed   Mentions: 11     Fields:    Translation:Humans
    87. Long-term changes in parathyroid function after subtotal thyroidectomy for graves' disease. World J Surg. 2008 Dec; 32(12):2612-6. Yano Y, Nagahama M, Sugino K, Ito K, Ito K. PMID: 18836764.
      View in: PubMed   Mentions: 4     Fields:    Translation:Humans
    88. Endoscopic tumor ablation for laryngotracheal intraluminal invasion secondary to advanced thyroid cancer. Acta Otolaryngol. 2008 Jul; 128(7):799-807. Tsutsui H, Usuda J, Kubota M, Yamada M, Suzuki A, Shibuya H, Miyajima K, Tanaka K, Sugino K, Ito K, Kato H. PMID: 18568524.
      View in: PubMed   Mentions: 5     Fields:    Translation:Humans
    89. Airway stenting for the treatment of laryngotracheal stenosis secondary to thyroid cancer. Respirology. 2008 Sep; 13(5):632-8. Tsutsui H, Kubota M, Yamada M, Suzuki A, Usuda J, Shibuya H, Miyajima K, Sugino K, Ito K, Furukawa K, Kato H. PMID: 18513246.
      View in: PubMed   Mentions: 8     Fields:    Translation:Humans
    90. Surgical management of Graves' disease -10-year prospective trial at a single institution. Endocr J. 2008 Mar; 55(1):161-7. Sugino K, Ito K, Nagahama M, Kitagawa W, Shibuya H, Ito K. PMID: 18250542.
      View in: PubMed   Mentions: 11     Fields:    Translation:Humans
    91. Recent outcome of Graves' disease patients with papillary thyroid cancer. Eur J Endocrinol. 2007 Sep; 157(3):325-9. Yano Y, Shibuya H, Kitagawa W, Nagahama M, Sugino K, Ito K, Ito K. PMID: 17766715.
      View in: PubMed   Mentions: 29     Fields:    Translation:Humans
    92. Paraganglioma of the thyroid: report of a male case with ultrasonographic imagings, cytologic, histologic, and immunohistochemical features. Thyroid. 2007 Jun; 17(6):575-8. Yano Y, Nagahama M, Sugino K, Ito K, Kameyama K, Ito K. PMID: 17614779.
      View in: PubMed   Mentions: 13     Fields:    Translation:Humans
    93. Management of differentiated thyroid carcinoma with radioiodine and recombinant human TSH. Endocr J. 2006 Dec; 53(6):723-8. Sugino K, Ito K, Takami H. PMID: 16960401.
      View in: PubMed   Mentions: 1     Fields:    Translation:Humans
    94. Childhood thyroid carcinoma with BRAFT1799A mutation shows unique pathological features of poor differentiation. Oncol Rep. 2006 Jul; 16(1):123-6. Kumagai A, Namba H, Mitsutake N, Saenko VA, Ohtsuru A, Ito M, Noh JY, Sugino K, Ito K, Yamashita S. PMID: 16786134.
      View in: PubMed   Mentions: 4     Fields:    Translation:Humans
    95. [Anaplastic carcinoma of the thyroid]. Nihon Rinsho. 2006 May 28; Suppl 1:485-8. Sugino K, Ito K. PMID: 16776196.
      View in: PubMed   Mentions:    Fields:    Translation:Humans
    96. [Metastatic tumors of the thyroid]. Nihon Rinsho. 2006 May 28; Suppl 1:497-9. Sugino K, Ito K. PMID: 16776199.
      View in: PubMed   Mentions:    Fields:    Translation:Humans
    97. A cavernous haemangioma of the thyroid gland. J Laryngol Otol. 2005 Oct; 119(10):828-30. Kano M, Kameyama K, Hosoda Y, Sugino K, Ito K. PMID: 16259665.
      View in: PubMed   Mentions: 4     Fields:    Translation:Humans
    98. Clinical evaluation of color Doppler imaging for the differential diagnosis of thyroid follicular lesions. World J Surg. 2004 Dec; 28(12):1261-5. Fukunari N, Nagahama M, Sugino K, Mimura T, Ito K, Ito K. PMID: 15517496.
      View in: PubMed   Mentions: 19     Fields:    Translation:Humans
    99. Low frequency of BRAFT1796A mutations in childhood thyroid carcinomas. J Clin Endocrinol Metab. 2004 Sep; 89(9):4280-4. Kumagai A, Namba H, Saenko VA, Ashizawa K, Ohtsuru A, Ito M, Ishikawa N, Sugino K, Ito K, Jeremiah S, Thomas GA, Bogdanova TI, Tronko MD, Nagayasu T, Shibata Y, Yamashita S. PMID: 15356022.
      View in: PubMed   Mentions: 24     Fields:    Translation:Humans
    100. Surgical treatment of Graves' disease in children. Thyroid. 2004 Jun; 14(6):447-52. Sugino K, Ito K, Mimura T, Fukunari N, Nagahama M, Ito K. PMID: 15242572.
      View in: PubMed   Mentions: 6     Fields:    Translation:Humans
    101. Composite metastatic carcinoma in lymph nodes of patients with concurrent medullary and papillary thyroid carcinoma: a report of two cases. Endocr Pathol. 2004; 15(1):83-8. Seki T, Kameyama K, Hayashi H, Nagahama M, Masudo K, Fukunari N, Tanaka K, Sugino K, Ito K, Takami H. PMID: 15067180.
      View in: PubMed   Mentions: 3     Fields:    Translation:Humans
    102. Lymph node metastasis from 259 papillary thyroid microcarcinomas: frequency, pattern of occurrence and recurrence, and optimal strategy for neck dissection. Ann Surg. 2003 Mar; 237(3):399-407. Wada N, Duh QY, Sugino K, Iwasaki H, Kameyama K, Mimura T, Ito K, Takami H, Takanashi Y. PMID: 12616125.
      View in: PubMed   Mentions: 206     Fields:    Translation:Humans
    103. Hyperthyroidism and the management of atrial fibrillation. Thyroid. 2002 Jun; 12(6):489-93. Shimizu T, Koide S, Noh JY, Sugino K, Ito K, Nakazawa H. PMID: 12165111.
      View in: PubMed   Mentions: 16     Fields:    Translation:Humans
    104. The important role of operations in the management of anaplastic thyroid carcinoma. Surgery. 2002 Mar; 131(3):245-8. Sugino K, Ito K, Mimura T, Nagahama M, Fukunari N, Kubo A, Iwasaki H, Ito K. PMID: 11894027.
      View in: PubMed   Mentions: 17     Fields:    Translation:Humans
    Kim's Networks
    Concepts (268)
    Derived automatically from this person's publications.
    _
    Co-Authors (1)
    People in Profiles who have published with this person.
    _
    Similar People (60)
    People who share similar concepts with this person.
    _
    Same Department
    Search Department
    _